Lawrence Recht

Clinical Trials

• Recruiting Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
• Not Recruiting XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
• Not Recruiting An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies
• Not Recruiting A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme
• Not Recruiting A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumor
• Recruiting Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
• Not Recruiting Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme
• Not Recruiting Phase 2 Study MPC-6827 for Recurrent Glioblastoma Multiforme
• Recruiting PI/II of Temozolomide & Hypofractionated Radiotherapy in Tx of Supratentorial Glioblastoma Multiform
• Not Recruiting A Study of Onartuzumab (MetMAb) in Combination With Bevacizumab Compared to Bevacizumab Alone or Onartuzumab Monotherapy in Patients With Recurrent Glioblastoma
• Not Recruiting Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
• Not Recruiting XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors
• Not Recruiting Phase I Trial of Arsenic Trioxide and Stereotactic Radiotherapy for Recurrent Malignant Glioma
• Not Recruiting Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT
• Recruiting Phase II NKTR-102 In Bevacizumab-Resistant High Grade Glioma